Effectiveness of Autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study

Freja Cordelia Møller Kirsebom, Julia Stowe, Jamie Lopez Bernal, Alex Allen, Nick Andrews
doi: https://doi.org/10.1101/2024.03.28.24305030

Article Information

doi 
https://doi.org/10.1101/2024.03.28.24305030
History 
  • March 29, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Freja Cordelia Møller Kirsebom, PhD*,1,
  2. Julia Stowe, PhD1,
  3. Jamie Lopez Bernal, PhD*,1,2,3,
  4. Alex Allen, BMBCh1 and
  5. Nick Andrews, PhD1,2
  1. 1UK Health Security Agency, London, United Kingdom
  2. 2NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom
  3. 3NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London, United Kingdom
  1. ↵*Corresponding author: Freja.kirsebom{at}ukhsa.gov.uk
Back to top
Posted March 29, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Effectiveness of Autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study
Freja Cordelia Møller Kirsebom, Julia Stowe, Jamie Lopez Bernal, Alex Allen, Nick Andrews
medRxiv 2024.03.28.24305030; doi: https://doi.org/10.1101/2024.03.28.24305030
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area